Literature DB >> 24894157

The significance of GBA for Parkinson's disease.

Kathrin Brockmann1, Daniela Berg.   

Abstract

From the first descriptions of Parkinson's disease (PD) and Gaucher's disease (GD) in the nineteenth century, it took more than 100 years to discover the link between the GBA gene and Parkinsonism. The observation that mutations in the GBA gene represent the most common genetic risk factor for PD so far only came into focus because of astute clinical observation of Gaucher patients and their families. In this review, we (i) outline how GBA was identified as a genetic risk factor for Parkinsonism, (ii) present clinical characteristics of GBA-associated Parkinsonism, (iii) discuss possible mechanisms of the underlying pathogenesis in GBA-associated Parkinsonism, and (iv) provide an outlook on potentially new areas of research and treatment that arise from this important discovery.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24894157     DOI: 10.1007/s10545-014-9714-7

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  42 in total

1.  Increased incidence of Parkinson disease among relatives of patients with Gaucher disease.

Authors:  Assaf Halperin; Deborah Elstein; Ari Zimran
Journal:  Blood Cells Mol Dis       Date:  2006-05-02       Impact factor: 3.039

2.  Differential phenotype in Parkinson's disease patients with severe versus mild GBA mutations.

Authors:  Z Gan-Or; N Giladi; A Orr-Urtreger
Journal:  Brain       Date:  2009-06-05       Impact factor: 13.501

3.  High frequency of the Gaucher disease mutation at nucleotide 1226 among Ashkenazi Jews.

Authors:  A Zimran; T Gelbart; B Westwood; G A Grabowski; E Beutler
Journal:  Am J Hum Genet       Date:  1991-10       Impact factor: 11.025

4.  Glucocerebrosidase is present in α-synuclein inclusions in Lewy body disorders.

Authors:  Ozlem Goker-Alpan; Barbara K Stubblefield; Benoit I Giasson; Ellen Sidransky
Journal:  Acta Neuropathol       Date:  2010-09-14       Impact factor: 17.088

5.  Occurrence of Parkinson's syndrome in type I Gaucher disease.

Authors:  O Neudorfer; N Giladi; D Elstein; A Abrahamov; T Turezkite; E Aghai; A Reches; B Bembi; A Zimran
Journal:  QJM       Date:  1996-09

Review 6.  Deregulated sphingolipid metabolism and membrane organization in neurodegenerative disorders.

Authors:  Marco Piccinini; Federica Scandroglio; Simona Prioni; Barbara Buccinnà; Nicoletta Loberto; Massimo Aureli; Vanna Chigorno; Elisa Lupino; Giovanni DeMarco; Annarosa Lomartire; Maria Teresa Rinaudo; Sandro Sonnino; Alessandro Prinetti
Journal:  Mol Neurobiol       Date:  2010-02-03       Impact factor: 5.590

Review 7.  Gaucher disease: mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA).

Authors:  Kathleen S Hruska; Mary E LaMarca; C Ronald Scott; Ellen Sidransky
Journal:  Hum Mutat       Date:  2008-05       Impact factor: 4.878

Review 8.  Gaucher disease: complexity in a "simple" disorder.

Authors:  Ellen Sidransky
Journal:  Mol Genet Metab       Date:  2004 Sep-Oct       Impact factor: 4.797

9.  Gaucher disease with parkinsonian manifestations: does glucocerebrosidase deficiency contribute to a vulnerability to parkinsonism?

Authors:  N Tayebi; J Walker; B Stubblefield; E Orvisky; M E LaMarca; K Wong; H Rosenbaum; R Schiffmann; B Bembi; E Sidransky
Journal:  Mol Genet Metab       Date:  2003-06       Impact factor: 4.797

10.  α-Synuclein genetic variants predict faster motor symptom progression in idiopathic Parkinson disease.

Authors:  Beate Ritz; Shannon L Rhodes; Yvette Bordelon; Jeff Bronstein
Journal:  PLoS One       Date:  2012-05-15       Impact factor: 3.240

View more
  11 in total

Review 1.  Psychosis in Parkinson's Disease: A Lesson from Genetics.

Authors:  Efthalia Angelopoulou; Anastasia Bougea; Sokratis G Papageorgiou; Chiara Villa
Journal:  Genes (Basel)       Date:  2022-06-20       Impact factor: 4.141

2.  Glucocerebrosidase and parkinsonism: lessons to learn.

Authors:  Ivanka Marković; Nikola Kresojević; Vladimir S Kostić
Journal:  J Neurol       Date:  2016-03-19       Impact factor: 4.849

3.  EPG5-related Vici syndrome: a paradigm of neurodevelopmental disorders with defective autophagy.

Authors:  Susan Byrne; Lara Jansen; Jean-Marie U-King-Im; Ata Siddiqui; Hart G W Lidov; Istvan Bodi; Luke Smith; Rachael Mein; Thomas Cullup; Carlo Dionisi-Vici; Lihadh Al-Gazali; Mohammed Al-Owain; Zandre Bruwer; Khalid Al Thihli; Rana El-Garhy; Kevin M Flanigan; Kandamurugu Manickam; Erik Zmuda; Wesley Banks; Ruth Gershoni-Baruch; Hanna Mandel; Efrat Dagan; Annick Raas-Rothschild; Hila Barash; Francis Filloux; Donnell Creel; Michael Harris; Ada Hamosh; Stefan Kölker; Darius Ebrahimi-Fakhari; Georg F Hoffmann; David Manchester; Philip J Boyer; Adnan Y Manzur; Charles Marques Lourenco; Daniela T Pilz; Arveen Kamath; Prab Prabhakar; Vamshi K Rao; R Curtis Rogers; Monique M Ryan; Natasha J Brown; Catriona A McLean; Edith Said; Ulrike Schara; Anja Stein; Caroline Sewry; Laura Travan; Frits A Wijburg; Martin Zenker; Shehla Mohammed; Manolis Fanto; Mathias Gautel; Heinz Jungbluth
Journal:  Brain       Date:  2016-03       Impact factor: 13.501

4.  GBA Variants Influence Motor and Non-Motor Features of Parkinson's Disease.

Authors:  Silvia Jesús; Ismael Huertas; Inmaculada Bernal-Bernal; Marta Bonilla-Toribio; María Teresa Cáceres-Redondo; Laura Vargas-González; Myriam Gómez-Llamas; Fátima Carrillo; Enrique Calderón; Manuel Carballo; Pilar Gómez-Garre; Pablo Mir
Journal:  PLoS One       Date:  2016-12-28       Impact factor: 3.240

5.  Reduced LRRK2 in association with retromer dysfunction in post-mortem brain tissue from LRRK2 mutation carriers.

Authors:  Ye Zhao; Gayathri Perera; Junko Takahashi-Fujigasaki; Deborah C Mash; Jean Paul G Vonsattel; Akiko Uchino; Kazuko Hasegawa; R Jeremy Nichols; Janice L Holton; Shigeo Murayama; Nicolas Dzamko; Glenda M Halliday
Journal:  Brain       Date:  2018-02-01       Impact factor: 13.501

Review 6.  Essential Tremor and Parkinson's Disease: Exploring the Relationship.

Authors:  Arjun Tarakad; Joseph Jankovic
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2019-01-09

7.  mTOR hyperactivity mediates lysosomal dysfunction in Gaucher's disease iPSC-neuronal cells.

Authors:  Robert A Brown; Antanina Voit; Manasa P Srikanth; Julia A Thayer; Tami J Kingsbury; Marlene A Jacobson; Marta M Lipinski; Ricardo A Feldman; Ola Awad
Journal:  Dis Model Mech       Date:  2019-10-16       Impact factor: 5.758

8.  Distinct Lysosomal Network Protein Profiles in Parkinsonian Syndrome Cerebrospinal Fluid.

Authors:  Andrea Boman; Samuel Svensson; Adam Boxer; Julio C Rojas; William W Seeley; Anna Karydas; Bruce Miller; Katarina Kågedal; Per Svenningsson
Journal:  J Parkinsons Dis       Date:  2016-04-02       Impact factor: 5.568

9.  Promising Metabolite Profiles in the Plasma and CSF of Early Clinical Parkinson's Disease.

Authors:  Daniel Stoessel; Claudia Schulte; Marcia C Teixeira Dos Santos; Dieter Scheller; Irene Rebollo-Mesa; Christian Deuschle; Dirk Walther; Nicolas Schauer; Daniela Berg; Andre Nogueira da Costa; Walter Maetzler
Journal:  Front Aging Neurosci       Date:  2018-03-05       Impact factor: 5.750

10.  Novel defect in phosphatidylinositol 4-kinase type 2-alpha (PI4K2A) at the membrane-enzyme interface is associated with metabolic cutis laxa.

Authors:  Miski Mohamed; Thatjana Gardeitchik; Shanti Balasubramaniam; Sergio Guerrero-Castillo; Daisy Dalloyaux; Sanne van Kraaij; Hanka Venselaar; Alexander Hoischen; Zsolt Urban; Ulrich Brandt; Raya Al-Shawi; J Paul Simons; Michele Frison; Lock-Hock Ngu; Bert Callewaert; Hans Spelbrink; Wouter W Kallemeijn; Johannes M F G Aerts; Mark G Waugh; Eva Morava; Ron A Wevers
Journal:  J Inherit Metab Dis       Date:  2020-06-26       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.